Answers are grounded in this paper and cite their sources.
The cellular immune defect in lepromatous leprosy has been studied. The following observations have been made: 1) Three lepromatous patients who had been on anti‐leprosy treatment for more than 10 years still failed to respond to M. leprae by lymphocyte transformation (mean 0.2%) while they responded strongly to BCG (mean 34.2%) and PPD (mean 56.1%). 2) Lepromatous serum failed to inhibit M. leprae‐induced lymphocyte transformation and M. leprae‐induced leukocyte migration inhibition. 3) Lepromatous lymphocytes revealed a reduced capacity to attach M. leprae to their surface. The only experimental condition compatible with the observed characteristics would seem to be a state of immunological tolerance to an antigen (or antigens) of M. leprae. The lasting nature of this non‐responsive state suggests that it plays a primary role in the pathogenesis of lepromatous leprosy.
No takes yet. Share an insight, caveat, or question.
Godal et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: